Activity of ceftazidime-avibactam combinations against carbapenem-resistant Klebsiella pneumoniae assessed by checkerboard method
Acta Microbiologica et Immunologica Hungarica · 2025
DOI: 10.1556/030.2025.02686 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Microbiologica et Immunologica Hungarica, 2025. Verfasst von Serpil Genç und 2 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, Department of Medical Microbiology, Kütahya Health Sciences University, Kütahya, Türkiye. Hauptthemen laut MEDLINE: Ceftazidime, Azabicyclo Compounds, Klebsiella pneumoniae, Anti-Bacterial Agents. Die Arbeit nennt 29 Literaturangaben.
Abstract (Originalsprache)
The aim of this study is to detect the carbapenemase type and to determine the in vitro effects of ceftazidime/avibactam-colistin, ceftazidime/avibactam-meropenem and ceftazidime/avibactam-tigecycline combinations against Carbapenem-Resistant Klebsiella pneumoniae (CRKP) isolates. A total of 35 CRKP isolates were included to the study. The minimum inhibitory concentrations of ceftazidime/avibactam, meropenem, colistin and tigecycline were determined by broth dilution method. Synergistic effects of ceftazidime/avibactam-colistin, ceftazidime/avibactam-meropenem and ceftazidime/avibactam-tigecycline were investigated by microdilution checkerboard method. Carbapenemase genes ( bla OXA-48 , bla NDM , bla KPC , bla IMP , bla VIM ) were detected by multiplex PCR. All of the isolates were resistant to meropenem, whereas 77.1% of the isolates were resistant to ceftazidime/avibactam and 14.3% of the isolates were resistant to colistin. The carbapenemase genes of the CRKP isolates were determined as 17 OXA-48+NDM, 9 KPC, 6 OXA-48, 1 NDM, 1 KPC+NDM and 1 KPC+OXA-48. Ceftazidime/avibactam-colistin, ceftazidime/avibactam-meropenem and ceftazidime/avibactam-tigecycline combinations were synergistic against 5.7% (2/35), 17.1% (6/35), and 5.7% (2/35) of the isolates, respectively. Ceftazidime/avibactam-meropenem was the most effective synergistic combination in our study, showing synergism in 17.1% of isolates, however, the synergistic effect varied depending on the CRKP isolate tested.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Medicine, Department of Medical Microbiology, Kütahya Health Sciences University, Kütahya, Türkiye.
ORCID-Profile: Serpil Genç
Zitieren
APA
Genç, S., Uzun, A. N., & Tanriverdi, H. (2025). Activity of ceftazidime-avibactam combinations against carbapenem-resistant Klebsiella pneumoniae assessed by checkerboard method. Acta Microbiologica et Immunologica Hungarica. https://doi.org/10.1556/030.2025.02686
Vancouver
Genç S, Uzun AN, Tanriverdi H. Activity of ceftazidime-avibactam combinations against carbapenem-resistant Klebsiella pneumoniae assessed by checkerboard method. Acta Microbiologica et Immunologica Hungarica. 2025. doi:10.1556/030.2025.02686
BibTeX
@article{Gen2025,
author = {Genç, Serpil and Uzun, Ayten Nur and Tanriverdi, Hilal},
title = {Activity of ceftazidime-avibactam combinations against carbapenem-resistant Klebsiella pneumoniae assessed by checkerboard method},
journal = {Acta Microbiologica et Immunologica Hungarica},
year = {2025},
doi = {10.1556/030.2025.02686}
}
EUVIMED